Abstract
Introduction and hypothesis
Management of stress urinary incontinence (SUI) with intravaginal devices is an alternative to surgical management, but data of a high level of evidence remain scarce. Our goal was to assess efficacy, tolerance, and acceptability of the 75NC007 intravaginal device for SUI management.
Methods
A phase III, multicenter randomized controlled trial was conducted. After an initial washout period with no treatment, allowing baseline evaluation, women with SUI were randomly assigned to a treatment or control group (no treatment). The primary endpoint was the reduction of incontinence episode frequency (IEF), according to bladder diaries, as compared to baseline. Secondary endpoints were variation of the Urinary Symptom Profile (USP) score, of 24-h pad test, and of CONTILIFE questionnaire scores as compared to baseline. Intent-to-treat and per-protocol analyses were conducted.
Results
Fifty-five patients were enrolled and analyzed (26 controls and 29 treated). The mean relative variations of IEF, SUI USP subscore, and overactive bladder (OAB) USP subscore were more significant in the treatment group than in the control group (−31.7 ± 65.1 % vs −7.6 ± 24.5 %, p = 0.002, −2.4 ± 2.6 vs 0.2 ± 2.2, p = 0.004, and −1.5 ± 2.8 vs 0.2 ± 1.8, p = 0.016, respectively). The dysuria USP subscore was slightly decreased in the treatment group. CONTILIFE scores were slightly improved in the treatment group. Pad test variations were not different between groups. No serious adverse event was noted throughout the entire study.
Conclusions
The 75NC007 intravaginal device is a safe and effective noninvasive treatment of SUI in women.
Similar content being viewed by others
References
Hunskaar S, Arnold EP, Burgio KL, Diokno AC, Herzog AR, Mallett VT (2000) Epidemiology and natural history of urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 11:301–319
Norton P, Brubaker L (2006) Urinary incontinence in women. Lancet 367(9504):57–67
Fultz NH, Burgio K, Diokno AC, Kinchen KS, Obenchain R, Bump RC (2003) Burden of stress urinary incontinence for community-dwelling women. Am J Obstet Gynecol 189:1275–1282
Coyne KS, Wein AJ, Tubaro A et al (2009) The burden of lower urinary tract symptoms: evaluating the effect of LUTS on health-related quality of life, anxiety and depression: EpiLUTS. BJU Int 103(S3):4–11
Hay-Smith J, Berghmans B, Burgio K et al (2009) Adult conservative management. In: Abrams P, Cardozo L, Khoury S, Wein A (eds) Incontinence: 4th International Consultation on Incontinence, 4th edn, Chap 12. Health Publications, Paris, pp 1025–1120
Goode PS, Burgio KL, Richter HE, Markland AD (2010) Incontinence in older women. JAMA 303:2172–2181
Richter HE, Albo ME, Zyczynski HM et al (2010) Retropubic versus transobturator midurethral slings for stress incontinence. N Engl J Med 362:2066–2076
van Kerrebroek P, Abrams P, Lange R et al (2004) Duloxetine versus placebo in the treatment of European and Canadian women with stress urinary incontinence. BJOG 111:249–257
Cardozo L, Drutz HP, Baygani SK, Bump RC (2004) Pharmacological treatment of women awaiting surgery for stress urinary incontinence. Obstet Gynecol 104:511–519
Richter HE, Burgio KL, Brubaker L, Nygaard IE, Ye W, Weidner A et al (2010) Continence pessary compared with behavioral therapy or combined therapy for stress incontinence: a randomized controlled trial. Obstet Gynecol 115:609–617
Farrell SA, Baydock S, Amir B, Fanning C (2007) Effectiveness of a new self-positioning pessary for the management of urinary incontinence in women. Am J Obstet Gynecol 196:474.e1–474.e8
Donnelly MJ, Powell-Morgan S, Olsen AL, Nygaard IE (2004) Vaginal pessaries for the management of stress and mixed urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 15:302–307
Nygaard I (1995) Prevention of exercise incontinence with mechanical devices. J Reprod Med 40:89–94
Komesu YM, Ketai LH, Rogers RG, Eberhardt SC, Pohl J (2008) Restoration of continence by pessaries: magnetic resonance imaging assessment of mechanism of action. Am J Obstet Gynecol 198:563.e1–563.e6
Lipp A, Shaw C, Glavind K (2011) Mechanical devices for urinary incontinence in women. Cochrane Database Syst Rev 7:CD001756
Haab F, Richard F, Amarenco G et al (2008) Comprehensive evaluation of bladder and urethral dysfunction symptoms: development and psychometric validation of the Urinary Symptom Profile (USP) questionnaire. Urology 71:646–656
Amarenco G, Arnould B, Carita P, Haab F, Labat JJ, Richard F (2003) European psychometric validation of the CONTILIFE: a Quality of Life questionnaire for urinary incontinence. Eur Urol 43:391–404
Shamliyan TA, Kane RL, Wyman J, Wilt TJ (2008) Systematic review: randomized, controlled trials of nonsurgical treatments for urinary incontinence in women. Ann Intern Med 148:459–473
Novara G, Artibani W, Barber MD, Chapple CR, Costantini E, Ficarra V et al (2010) Updated systematic review and meta-analysis of the comparative data on colposuspensions, pubovaginal slings, and midurethral tapes in the surgical treatment of female stress urinary incontinence. Eur Urol 58:218–238
Yalcin I, Peng G, Viktrup L, Bump RC (2010) Reductions in stress urinary incontinence episodes: what is clinically important for women? Neurourol Urodyn 29:344–347
Farrell SA (2001) Pessaries for the management of stress urinary incontinence. J Obstet Gynaecol Can 23:1184–1189
Robert M, Mainprize TC (2002) Long-term assessment of the incontinence ring pessary for the treatment of stress incontinence. Int Urogynecol J Pelvic Floor Dysfunct 13:326–329
Simpson SH, Eurich DT, Majumdar SR et al (2006) A meta-analysis of the association between adherence to drug therapy and mortality. BMJ 333:15
Farrell SA, Singh B, Aldakil L (2004) Continence pessaries in the management of urinary incontinence in women. J Obstet Gynaecol Can 26:113–117
Acknowledgments
The authors thank B.BRAUN Medical SAS for their funding support.
The authors thank the other 75NC001 Study Group investigators who participated in the conduct of the trial included the following: O. Chevallier, MD, Paris, France; P. Grise, MD, Rouen, France; JF Hermieu, MD, Paris, France; C Jouffroy, MD, Metz, France; L. Lenormand, MD, Nantes, France; C Marhic, MD, Vincennes, France; T Mouchel, MD, Le Mans, France; JL Pouch, MD, Paris, France.
Conflicts of interest
Professor Stephane Mouly received consultancy honoraria from B. Braun, Pfizer, Sanofi-Aventis, Lilly Research Laboratories, Lundbeck and Chugai Pharma. Other authors have no conflicts of interest to declare.
Author information
Authors and Affiliations
Consortia
Corresponding author
Rights and permissions
About this article
Cite this article
Cornu, JN., Mouly, S., Amarenco, G. et al. 75NC007 device for noninvasive stress urinary incontinence management in women: a randomized controlled trial. Int Urogynecol J 23, 1727–1734 (2012). https://doi.org/10.1007/s00192-012-1814-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00192-012-1814-z